Canada Markets open in 9 hrs 21 mins

Exactus, Inc. (EXDI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.07000.0000 (0.00%)
At close: 1:09PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0700
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0700 - 0.0700
52 Week Range0.0400 - 0.2670
Avg. Volume87,221
Market Cap7.83M
Beta (5Y Monthly)4.32
PE Ratio (TTM)N/A
EPS (TTM)-0.2310
Earnings DateJul. 01, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities

    22nd Century Takes Ownership of Needle Rock Farms, Provides North American Cultivation Base of OperationsBUFFALO, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced it has signed a definitive agreement to restructure its strategic investment in Panacea Life Sciences, Inc., in line with the ongoing development of


    Exactus Joins with Panacea Life Sciences to Create Premier CBD Wellness Platform

    Leslie Buttorff, Founder of Panacea, To Lead Combined Companies as Chief Executive OfficerDELRAY BEACH, FL / ACCESSWIRE / July 1, 2021 / Exactus, Inc. (OTCQB:EXDI) (the "Company") a leading supplier of hemp-derived ingredients (CBD/CBG), today announced the acquisition of Panacea Life Sciences, Inc.


    Exactus, Inc. Reports Third Quarter 2020 Financial Results

    Third Quarter 2020 Highlights * Total Net Revenue of $678,050 * Achieved Gross Profit of $114,529 * Continuation of Sales & Marketing Buildout * Alibaba Storefront LaunchDELRAY BEACH, FL / ACCESSWIRE / November 19, 2020 / Exactus, Inc.